Ninerafaxstat not checked
Imbria Pharmaceuticals, Inc. · IMB-1018972
FollowEvery change as it happens, and a Monday email
Trials
1 active
5 in total · 1 in the EU
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Ninerafaxstat 200mg Modified Release tablet administered BID”In the company’s words, NCT07023614 on ClinicalTrials.gov
- Main trialPhase 2
- “FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard of Care in patients with symptomatic nHCM”In the company’s words, NCT07023614 on ClinicalTrials.gov
- Other names
- IMB-1018972
Other drugs for Non-obstructive Hypertrophic Cardiomyopathy
- SotagliflozinLexicon Pharmaceuticals · Phase 3
- HRS-1893Hengrui · Phase 3
- BHB-1893Braveheart Bio, Inc. · Phase 3
- AficamtenCytokinetics · Phase 2/3
- BAY3723113Bayer · Phase 3
- QG101-23-0Amckaus PTY LTD. · Phase 2
Coming up1
- DecPhase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | Dec 2026 | A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy | |
| Phase 2Completed | 18 Sep 2023 | A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial | |
| Phase 2Completed | 21 Sep 2023 | Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia) | |
| Phase 2Completed | 6 Aug 2024 | IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2) | |
| Phase 2Withdrawn | Feb 2025 | A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026